Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210028028 210013671 1.77 54.4 Curative (C) 2016-03-29 2016-03-29 Gemcitabine + Oxaliplatin 02 N 210042169 BEVACIZUMAB + TEMOZOLOMIDE
210028029 210013672 null 50 Disease modification (D) 2018-04-05 2018-05-12 CISPLATIN + VINCRISTINE N null 210042169 CYCLOPHOSPHAMIDE HIGH DOSE
210028030 210031544 null null Palliative (P) 2017-02-13 2017-02-13 Cyclophosphamide High Dose null N 210000982 CYCLOPHOSPHAMIDE HIGH DOSE
210028031 210013675 1.53 null Curative (C) 2018-04-22 2018-09-25 Gemcitabine + Oxaliplatin N N 210001193 CYTARABINE
210028032 210013677 0 58 Curative (C) null 2017-09-16 Mitomycin Intravesical N N 210001293 PACKER MAINTENANCE
210028033 210028143 null null Curative (C) 2018-11-12 2018-11-12 Bortezomib + CYCLOPHOSPHAMIDE N N 210004103 DOCETAXEL
210028034 210022544 1.69 41.2 Curative (C) 2016-02-27 2016-05-29 Bortezomib + MELPHALAN 02 N 210005567 GEMCITABINE
210028035 210022544 null 35.5 Curative (C) 2018-04-05 2018-07-13 IDARUBICIN null N 210005567 ECX
210028036 210013682 1.69 99 Curative (C) 2013-11-23 2013-11-29 PEMBROLIZUMAB null null 210008338 CVP
210028037 210013683 0 null Curative (C) 2018-11-11 2018-11-16 IVE-R N 0 210008519 TAMIGA TRIAL
210028038 210013685 null 72.6 null 2016-02-07 2016-02-07 Obinutuzumab null N 210008669 FLUDARABINE
210028039 210013687 null 70.8 Curative (C) 2017-09-10 2018-01-02 Bevacizumab + LOMUSTINE Y null 210008796 HYDROXYCARBAMIDE
210028040 210013689 1.81 26.8 Palliative (P) 2017-08-30 2017-09-15 RUXOLITINIB N N 210008846 BENDAMUSTINE + OFATUMUMAB
210028041 210013690 null 71.5 Curative (C) null 2017-09-01 Fludarabine oral 02 N 210010376 IRINOTECAN + MDG
210028042 210031547 null 32.5 Curative (C) 2017-08-05 2017-08-05 Paclitaxel (2 or 3 weekly) N N 210011776 CYTARABINE INTRATHECAL
210028043 210013692 1.66 null Curative (C) 2017-10-19 2017-10-19 CLARITY Trial N N 210011848 CLARITY TRIAL
210028044 210013695 1.78 23 Curative (C) 2019-01-18 2019-01-18 CLARITY Trial N N 210012655 CYCLOPHOSPHAMIDE HIGH DOSE
210028045 210013697 0 79 Curative (C) 2016-12-05 2016-12-20 ABVD Y Y 210014040 ALEMTUZUMAB + CYCLOPHOSPHAMIDE + METHOTREXATE
210028046 210013699 null 63 Curative (C) 2018-09-17 2018-12-06 Cyclophosphamide High Dose N Y 210014521 CVP
210028047 210013701 0 98.8 Curative (C) 2016-04-06 2017-09-26 CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE 01 N 210017128 CHOEP
210028048 210013701 null null Curative (C) 2017-04-25 2018-05-15 Cytarabine low (10to20mg/m2) IV/SC 02 N 210017128 CYTARABINE + RITUXIMAB
210028049 210013701 1.76 99.9 Curative (C) 2018-03-21 2018-04-06 Consolidation - Cycle 2 & 4 (ALL) 02 N 210017128 CODOX M
210028050 210013704 1.62 63.2 Curative (C) 2017-09-18 2017-10-24 POMALIDOMIDE Y N 210019353 HYDROXYCARBAMIDE
210028051 210013704 1.64 102 Disease modification (D) 2018-08-18 2018-08-27 FLUOROURACIL + IRINOTECAN + PANITUMUMAB 2 N 210019353 IDARUBICIN
210028052 210013706 1.79 90 Curative (C) 2019-04-24 2019-04-25 Abiraterone N N 210021249 CLL210 TRIAL
210028053 210022562 1.52 6.25 Palliative (P) 2018-10-10 2018-11-19 ALL UKALL2003 C: Ph VII Maintenance 02 N 210021270 R-EPOCH
210028054 210013708 null null Palliative (P) 2017-12-31 2018-01-21 OFATUMUMAB 2 N 210021324 CYTARABINE + ETOPOSIDE
210028055 210013711 1.68 61 Adjuvant (A) 2018-11-08 2018-11-08 CYCLO + ETOPOSIDE + NELARABINE null N 210021498 CYTARABINE
210028056 210028160 1.78 83 Palliative (P) 2017-04-23 2017-07-25 IDARUBICIN N N 210021743 CODOX M
210028057 210013714 0.93 21 Curative (C) 2005-09-03 2016-07-16 PENTOSTATIN + RITUXIMAB 2 N 210021743 ALL INDUCTION
210028058 210022569 1.68 82.3 null 2019-01-30 2019-08-07 FLUDARABINE + MELPHALAN Y null 210021885 FLUDARABINE + RITUXIMAB
210028059 210013717 0 75.6 Curative (C) 2017-07-30 2017-07-31 ALL UKALL2003 C: Ph VII Maintenance N N 210021911 RCEOP
210028060 210013719 1.69 null Curative (C) 2016-05-06 2016-05-06 Cytarabine Intrathecal (any age) N N 210022095 DHAP - R
210028061 210013722 1.72 null Curative (C) 2016-11-01 2016-11-01 PNET 4 HIT-SIOP Maintenance null N 210022095 IGEV R
210028062 210013722 1.75 82.3 Curative (C) 2018-12-27 2018-12-27 DACTINOMYCIN + CYCLO + VINCRISTINE N N 210022095 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE
210028063 210013723 1.76 null Adjuvant (A) 2019-04-12 2019-04-12 Consolidation - Cycle 1 (ALL) N N 210022560 CVP
210028064 210013724 0.94 68.6 Curative (C) null 2015-10-11 LENALIDOMIDE + dexamethasone 02 N 210022634 CYTARABINE HIGH DOSE
210028065 210013726 1.76 90 Curative (C) 2013-08-06 2013-08-06 CLARITY Trial N null 210022799 CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE
210028066 210013729 1.87 97.9 Curative (C) 2017-03-31 2017-04-07 TAMIGA trial 01 N 210023716 OFATUMUMAB
210028067 210031557 1.61 99 Curative (C) 2008-07-20 2015-01-29 Nilotinib N null 210023719 CLARITY TRIAL
210028068 210013732 1.83 54.1 Adjuvant (A) 2015-08-16 2017-11-09 CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE null null 210023909 DOCETAXEL
210028069 210013734 1.72 28.7 Curative (C) 2016-07-25 2016-08-01 PNET 4 HIT-SIOP Maintenance N N 210024019 FLUDARABINE
210028070 210013736 1.9 68.5 Disease modification (D) 2019-04-15 2019-05-19 Carboplatin + Paclitaxel (3 weekly) N N 210024036 ALL MAINTENANCE
210028071 210013737 1.57 47 Curative (C) 2019-02-02 2019-09-20 CLL210 TRIAL N N 210024115 NILOTINIB
210028072 210013738 1.56 47 Adjuvant (A) null 2016-09-06 CISPLATIN + ETOPOSIDE + IFOSFAMIDE N N 210024200 ICE-R
210028073 210013740 1.83 63.5 null 2015-10-04 2015-10-04 CISPLATIN + ETOPOSIDE N N 210024335 IMMUNOGLOBULIN
210028074 210022581 1.85 80 Curative (C) null 2015-11-18 Dactinomycin + Vincristine 02 N 210024647 BR14 TRIAL
210028075 210013743 1.67 49.7 Curative (C) 2017-04-01 2017-04-01 CNS LGG Irinotecan & Bevacizumab Y N 210024808 FLUOROURACIL
210028076 210013744 0 null Disease modification (D) 2019-01-25 2019-01-25 DA-EPOCH-R N N 210024837 DOCETAXEL
210028077 210022584 null 63.3 null 2018-05-15 2018-07-08 CNS Medbl Std Risk Maint Cisplatin N N 210025000 CLADRIBINE + RITUXIMAB